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The purpose of this study was to assess the difference in satisfaction of using seat elevators (SE) 
on power wheelchairs among individuals with disabilities through retrospective analysis of two 
clinical quality assurance databases that included time 1 (T1) and time 2 (T2) Functional 
Mobility Assessment (FMA) scores.  The FMA is a validated self-report questionnaire that 
measures a person’s satisfaction in performing Mobility Related Activities of Daily Living 
(MRADL) across 10 items (Kumar, 2013).  The databases collectively held 731 cases while 123 
cases met the inclusion criteria of using a power wheelchair equipped with a SE at either T1, T2, 
or both.  Three aspects of the FMA were assessed; #5 (reach), #6 (transfer), and total score.  
Cases were assigned to one of the three following groups; power wheelchair (PWC) users using 
a device with a SE at T1 but using a new device without a SE at T2 (SE – NSE, n = 14); PWC 
users using a device with a SE at T1 and using a device with a SE at T2 (SE – SE, n = 42); and 
PWC users using a device without a SE at T1 but using a device with a SE at T2 (NSE – SE, n = 
67).  The three aspects of the FMA were analyzed within the three groups of PWC users. For the 
SE-NSE group, there was a significant decrease for FMA item #5 (reach) (p = .03).  There were 
no significant changes for FMA item #6 (transfer) (p = .48) and total score (p = .57).  For the SE-
SE group, there were significant improvements in FMA items #5 (reach) (p < .01), #6 (transfer) 
(p < .01), and total score (p < .01).  For the NSE-SE group, there were significant improvements 
for FMA items #5 (reach) (p < .01), #6 (transfer) (p < .01), and total score (p < .01).  In 
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summary, the study indicates a SE can increase satisfaction of PWC users.  The lack of a 
statistically significant difference in FMA item #6 and FMA total for the SE – NSE group was 
likely due to a small sample in that subgroup. 
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1.0  INTRODUCTION 
1.1 BACKGROUND 
Types of wheeled mobility seating related devices include manual wheelchairs, power scooters, 
and power wheelchairs.  The Rehabilitation Engineering Society of North America (RESNA) 
Wheelchair Service Provision Guide provides an insight to the proper wheelchair service process 
by identifying need, assessment of current technology and environment, equipment 
recommendation and selection, funding options, fitting and delivery, follow up and maintenance, 
and lastly, outcome measurement (Arledge et al., 2011).  Medicare policy requires that for any 
mobility assistive equipment to be covered, it must improve or maintain a person’s ability to 
perform Mobility Related Activities of Daily Living (MRADL) such as toileting, feeding, 
dressing, grooming, and bathing within the home (Center for Medicare and Medicaid Services, 
2016).  Several seat functions can be added to a power wheelchair such as tilt-in-space, backrest 
recline, and elevating leg rests to address medical issues (Dicianno, Arva, Lieberman, Schmeler, 
Souza, et al., 2009). The RESNA Position Paper on Seat Elevating Devices (Arva, Schmeler, 
Lange, Lipka, & Rosen, 2005) acknowledges that individuals with disabilities who utilize power 
wheelchairs move in a three dimensional world.  This is sometimes overlooked as the majority of 
power wheelchairs only move forward, backward, left, and right.  In addition, the base of the 
power wheelchair allows for the addition of a seat elevator for vertical movement.  This is a 
common accessory on power wheelchairs which provides individuals the ability to perform 
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MRADL such as transferring and reaching (Arva et al., 2005).  The Wheelchair Evaluation: A 
Clinician’s Guide (Batavia, 2010) states that seat elevation optimizes transfer position, facilitates 
reaching high selves, and facilitates socialization by talking face to face.  Biomechanically, the 
hip and knee joints experience a decrease range of motion when transferring from a higher to a 
lower seat height (Burdett, Habasevich, & Pisciotta, 1985).  Reaching objects at a higher seat 
height impacts upper extremity joints significantly different compared to lower seat heights, 
specifically the cervical spine and glenohumeral joints (Sabari, Shea, & Chen, 2015).  According 
to the National Kitchen and Bath Association (NKBA) (2016) the recommended maximum 
height for a stove is 34 inches and the location of the controls should not be in a position where 
individuals need to reach across the burners.  Also according to NKBA (2016), Microwave oven 
controls have a recommended maximum height of 48 inches.  These heights are only 
recommendations and may not take into account the specific needs of a wheelchair user reaching 
over a stove to prepare hot food.  In conclusion, Medicare has determined that seat elevators are 
not a covered benefit as they are not medically necessary (Centers for Medicare and Medicaid 
Services Coverage Guidance by NHIC Corp., 2015).  The purpose of this study is to investigate 
power wheelchair (PWC) user satisfaction in performing reach tasks, transfer tasks, and overall 
satisfaction in performing MRADL with and without SE. 
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1.2 RELATED RESEARCH 
1.2.1 Functional Mobility Assessment (FMA) 
The Functional Mobility Assessment (FMA) is a validated self-report questionnaire that 
measures a person’s satisfaction in performing MRADL across 10 items.  It serves as an outcome 
measure that can be administered and compares pre and post-delivery of a mobility device or 
intervention.  The FMA is reported to have test-retest reliability with Intraclass Correlation 
Coefficient of 0.87 which is above the accepted value of ICC ≥ 0.80 (Kumar et al, 2013).  Two 
items of the FMA specifically, report recorded test-retest reliability values for item #5, reach 
(ICC = 0.83) and item #6, transfer (ICC = 0.81) (Kumar et al., 2013). The FMA is a derivative of 
previously validated self-report and observation tools known as the Functioning Everyday with a 
Wheelchair (FEW), Functioning Everyday with a Wheelchair – Capacity (FEW-C), and 
Functioning Everyday with a Wheelchair – Performance (FEW-P) (Schmeler, 2005).  The 
original FEW questionnaire has reported acceptable test-retest reliability of ICC = 0.92 for 
version 1 and ICC = 0.86 for version 2 (Mills, Holm, & Schmeler, 2007).  Two additional studies 
show the FEW was cross-validated with consumer goals in the process of development (Mills et 
al., 2002a; Mills et al., 2002b).  
The (FEW-C) was examined for inter-rater reliability (ICC = 0.97) (Schmeler, 2005).  
The validity of the 10 items of the FEW and the 10 items of the FMA are congruent with one 
another.  The only difference is the FMA focuses on mobility in general while the FEW focuses 
on wheelchairs specifically.  The FMA was developed from the FEW by rewording the 
statements to remove reference to wheelchair or scooter as many people with mobility 
impairments seen at initial clinical evaluation for a device or intervention were not using a 
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wheelchair or scooter therefore difficult to obtain a baseline score for comparison post-
intervention (Kumar et al., 2013). 
 
1.2.2 Seat Elevators on Power Wheelchairs 
Seat functions such as tilt-in-space, recline, and elevating seats are commonly used by 
wheelchair users to perform MRADL (Arva et al., 2005; Dicianno et al., 2009).  According to 
Ding et al. (2008) six individuals who use power wheelchairs equipped with seat elevators 
reported using the accessory four times per day on average.  Seat elevators were used to 
complete tasks such as reaching higher levels, transfers, working at different levels, shopping, 
sitting at a bar, accessing light switches, toileting, socializing, eating, reading calendars on the 
refrigerator, and reaching elevator buttons.   
Liu, Cooper, Kelleher, and Cooper (2014) reported on the use of power seat functions 
(tilt-in-space, recline, elevating legrests, and seat elevators) in the natural environment of five 
wheelchair users.  The participants reported that power seat elevators were beneficial in reaching 
over shoulder height and standing up.  
 
1.2.3 Transfers in Reference to Seat Height 
Edlich, Heather, and Galumbeck (2003) performed a systematic review to investigate limitations 
in the ability to perform to sit-to-stand transfers and found presence of pain, reduced joint range 
of motion, joint stiffness, and muscle weakness as contributing factors.  Lower moments of the 
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knee and hip joints at higher chair height were a result of the study.  Other factors such as arm 
rest use and feet repositioning also contributed to a person’s ability to stand.  The review also 
indicated higher seat heights benefit healthcare personnel by eliminating the need to lift the 
individual while standing from a seated position. 
Janssen, Bussmann, and Stam (2002) performed a review of 39 studies that fit the criteria 
of sit-to-stand transitions.  The review found that a number of factors can influence sit to stand 
performance including seat height, armrests, and foot positioning.  Specifically, the review 
indicates that a higher seat height results in lower force moments at the hip and knee level and 
that upper and lower extremity joints are affected by seat height during transfer.  
Alexander, Gross, Medell, and Hofmeyer (2000) reported that biomechanically, standing 
from a lower seat height increased joint torque at the hip and knee joint.  The study consisted of 
16 participants who completed a 12 week strength-training program.  The assessment included 7 
chair rise tasks in which the effects of seat height adjusted to three different angles of flexed 
knee height were analyzed.   
Burdett, Habasevich, and Pisciotta (1985) examined wheelchair transfers by measuring 
range of motion at the ankle, knee, and hip joints.  The initial seating height of the participant 
observed was 0.43 meters and the second height observed was 0.64 meters.  The study included 
14 participants overall and was a mix between able and disabled users.  The study found that 
significantly smaller hip and knee flexion were observed using a higher seat height.  The study 
concluded that the use of a higher seat height while rising out of a chair is less stressful on joints.  
The study noted that similar results were found in both able bodied and persons with disabilities. 
Crytzer, Cooper, Jerome, and Koontz (2015) examined factors that allow individuals to 
independently transfer from one surface to another and perform activities of daily living. 
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Participants for the study included 38 individuals who voluntarily participated.  These volunteers 
consisted of experts in the field of assistive technology.  As a result, user issues, factors, 
concerns, transfer process, transfer techniques, transfer preferences, built environment, and 
transfer training evaluation were determined to be the relevant goals.  The relevant goals were 
used to determine research needs. 
Toro, Koontz, and Cooper (2012) investigated the impact of transfer setup on the 
performance of independent wheelchair transfers.  This study included 120 participants who 
performed transfers onto a height adjustable platform.  The participants included were wheeled 
mobility users.  The results showed highest and lowest heights of transferring were similar to the 
median seat to floor height (56 centimeters) of wheelchair users.  
Gagnon, Nadeau, Desjardins, and Noreau (2007a) looked at kinematic factors in a case 
study involving one subject with a T6 spinal cord injury performing a sit to pivot transfer from 
two stationary platforms at a height of 50 centimeters and 60 centimeters.  The findings showed 
that transferring to the higher surface resulted in greater elbow flexion and shoulder adduction.  
In a subsequent study of similar methods (Gagnon, Nadeau, Noreau, Eng, & Gravel, 2007b) ten 
participants with spinal cord injuries performed transfers to a 70 centimeter high seat height and 
a 40 centimeter lower eat height.  Results indicated that time to complete transfers did not 
change from the case study however shoulder and elbow joint range of motion was more 
pronounced as height increases.   
In conclusion, the literature shows that upper extremity and lower extremity joints are 
affected by seat height during transfers.  Transferring from a higher to a lower height results in 
less strain to the upper and lower extremities as compared to transferring from a lower to a 
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higher height which can have significant impact on individuals with weakness or repetitive strain 
injuries. 
 
1.2.4 Reaching in Reference to Seat Height 
Sabari, Shea, and Chen (2015) studied the impact of wheelchair seat height on neck and shoulder 
range of motion and the ability of individuals to perform functional reach tasks.  This 
observational study examined active range of motion for cervical extension and shoulder 
abduction as well as physical stature.  The participants included 60 ambulatory adults seated 
symmetrically in a power wheelchair.  Each participant was required to complete two tasks at 
normal seat height and maximum seat height.  The tasks included viewing a tablet at a height 
above the head of the participant and hitting a switch with minimal movement using their index 
finger.  The results indicate that wheelchair seat height impacts shoulder abduction and cervical 
extension active range of motion while performing reaching tasks.  A larger active range of 
motion is needed to perform reaching tasks at a lower seat height. 
1.2.5 Seat Elevator Funding 
The Veterans Health Administrations Prosthetic Clinical Management Programs (U.S. 
Department of Veterans Affairs, 2004a) and the Clinical Practice Recommendations for 
Motorized Wheeled Mobility Devices (U.S. Department of Veterans Affairs, 2004b) outlines the 
recommendations for prescribing seat lift mechanisms.  The medical criteria notes that “the use 
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of a seat lift mechanism is to make transferring from a seating position easier”.  The VA will 
cover the cost of a seat elevator as long as the Veteran meets the necessary requirements. 
Medicare outlines the coverage of stationary seat lifts chairs for in the Medicare National 
Coverage Determinations Manual (Centers for Medicare and Medicaid Services, 2016).  The 
coverage is limited to effectively assisting a patient in standing up or sitting down without other 
assistance.  The Centers for Medicare and Medicaid Services Coverage Guidance provided by 
the National Health Insurance Company (NHIC) Corporation (2015) provides a Wheelchair 
Options/Accessories document (L33792) that states “power seat elevation features are non-
covered because they are not primarily medical in nature”.  No further rationale is given for this 
policy.  Additionally, funding from state Medicaid programs and private programs are available 
however most follow the Medicare policy.  In conclusion, seat elevators can be covered by 
certain payers but denied by other payers. 
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2.0  ASSESSMENT OF SEAT ELEVATOR SATISFACTION 
2.1 INTRODUCTION 
In the United States, 38.3 million (12.6% of the U.S. population1) non-institutionalized 
individuals had a severe disability in 2010 and 12.3 million individuals (4.4% of U.S. 
population1) need assistance with one or more activities of daily living.  As reported, 3.6 million 
individuals use a wheelchair and 11.6 million individuals use a cane, crutch, or walker (Brault, 
2012).  The Brault study, consisting of 241,682 individuals were asked if they could perform 
individual tasks, 5% reported that they had difficulty reaching for objects overhead.   
These numbers focus on the United States population in past years and reflect the need of 
an intervention.  Insurance plays a role in the lives of individuals with disabilities as 81.7% of 
individuals report making <$25,000 per year (Brault, 2012).  This affects the individuals’ ability 
to pay for certain assistive technology that is not covered under insurance.  This reflects the 21% 
of individuals reporting that they were not enrolled in any health insurance coverage in 2010 
(Brault, 2012).  Medicare does not currently fund seat elevating devices as they do not consider 
them medically necessary (Centers for Medicare and Medicaid Services, 2016).  The VA allows 
Veterans the use of seat elevators on their mobility device as long as certain functional criteria 
                                                 
1 Based on the 2010 U.S. Census Population of 308,745,538 
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are met (U.S. Department of Veterans Affairs, 2004b).  Certain states have programs that may 
offer assistance with seat elevator funding as well as private payment by private insurance or the 
user themselves (Groah, Ljungberg, Lichy, Oyster, & Boninger, 2014). 
Outcome measures have become a necessity in all aspects of health care service delivery 
including wheeled mobility and seating (Arledge et al., 2011).  The process begins by collecting 
baseline data related to a personal event or action (Hersen, 2004).  The data is then collected at a 
second point in time and is considered an outcome measurement.  Information from outcome 
measurement can be used to evaluate and improve the quality of care for individuals (Lohr, 
1988).  An outcome measure is ideally obtained by using a standardized tool such as the FMA.  
The FMA is a self-report consumer centered questionnaire to assess a person’s satisfaction in 
performing MRADL.  It can also be used as an outcome measure when administered post-
intervention.  The FMA consists of ten statements (carrying out daily routine, meeting comfort 
needs, meeting health needs, ability to operate, reaching and carrying out tasks at different 
surface heights, transferring, carrying out personal care tasks, getting around indoors, getting 
around outdoors, and using public or personal transportation) (Kumar et al., 2013) (Appendix A).  
These ten statements pertain to consumer satisfaction with overall mobility related to activities of 
daily living.  Two statements from the FMA refer to the satisfaction with reaching and carrying 
out tasks at different surface heights and transferring from one surface to another.  These two 
statements can be impacted by seat height and the functional ability of the individual to perform 
these tasks (Sabari et al., 2016; Burdett et al., 1985; Janssen, Bussman, & Stam, 2002; Alexander 
et al., 2000). 
The use of a seat elevator is the main focus of this study.  Three null hypotheses align with 
the three groups in the study and are listed as follows: 
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• Null Hypothesis 1: There will be no statistically significant difference in FMA item #5 
(reach), item 6 (transfer), or total FMA scores for power wheelchair users who have a 
device equipped with a seat elevator at Time 1 compared to the same measures when the 
user has a new device unequipped with a seat elevator at Time 2.   
• Null Hypothesis 2: There will be no statistically significant difference in FMA item #5 
(reach), item 6 (transfer), or total FMA scores for power wheelchair users who have a 
device equipped with a seat elevator at Time 1 compared to the same measures when the 
user has a new device equipped with a seat elevator at Time 2.   
• Null Hypothesis 3: There will be no statistically significant difference in FMA item #5 
(reach), item 6 (transfer), or total FMA scores for power wheelchair users who have a 
device unequipped with a seat elevator at Time 1 compared to the same measures when 
the user has a new device equipped with a seat elevator at Time 2.   
2.2 METHODS 
2.2.1 Study Design 
This study was a retrospective analysis of data collected under an approved quality assurance 
initiative.  The study consisted of two separate databases that contained time 1 (pre) FMA scores 
and time 2 (post) FMA scores of 731 wheelchair users.  Participants in the databases were 
divided into the following three groups: 
- individuals with disabilities who were using a seat elevator initially at time 1 and lost the 
seat elevator at Time 2 (n = 14), 
 12 
- individuals with disabilities who were using a seat elevator at Time 1 and maintained the 
seat elevator at Time 2 (n = 42), 
- individuals with disabilities who were not using a seat elevator at Time 1 and obtained a 
seat elevator at Time 2 (n = 67). 
At each time point (time 1 and time 2) the FMA scores were collected by a rehabilitation 
professional or student in a rehabilitation field.  Time 1 FMA scores were collected at any time 
between 04/08/2008 – 08/18/2015.  Time 1 FMA scores were recorded in seating clinics by 
rehabilitation professionals.  Time 2 FMA questionnaires were performed at any time between 
11/29/2010 – 02/22/2016.  At any given data point, FMA time 2 scores were recorded no less 
than 21 days post-delivery.  Time two FMA scores were collected by rehabilitation professionals 
by phone, letter, or face-to-face.  The FMA data were extracted from both databases.  When 
available, additional demographic variables were collected including gender, age, primary 
diagnosis, and primary insurance (Table 1).  
 
2.2.2 Participants 
Cases for inclusion met the following criteria: 
- Seat elevator was recommended 
- Time 1 FMA was completed 
- Time 2 FMA was completed 
- Cases had a power wheelchair at time 1 and time 2 
- Age of 18 years or older. 
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The 123 cases were retrieved from two databases.  The first database was housed at the 
Department of Rehabilitation Science and Technology (RST) at the University of Pittsburgh (n = 
483) and included a collection of de-identifiable data from multiple seating clinics in which 41 
cases met the inclusion criteria.  The second database was from the Center for Assistive 
Technology at the University of Pittsburgh Medical Center (UPMC/CAT) (n = 248) in which 83 
cases met the inclusion criteria.     
2.2.3 Instruments 
The only instrument included in this study was the Functional Mobility Assessment (FMA).  The 
tool was administered at two time points and was performed by rehabilitation professionals such 
as students in the field of rehabilitation science, clinicians, or suppliers.  Individuals who 
performed the FMA were experienced and had some training in use of the tool prior to 
administering it.  The 10 statements of the FMA can have a response of 1-6 with 1 as completely 
disagree with the statement, 2 as mostly disagree with the statement, 3 as slightly disagree with 
the statement, 4 as slightly agree with the statement, 5 as mostly agree with the statement, and 6 
as completely agree with the statement (Appendix B).  Additional comments can be recorded 
under each statement however this was not collected or analyzed.  All individuals who 
completed the FMA had to be cognitively able to answer by speaking themselves, pointing to the 
response, or facilitating their response to a proxy to relay the appropriate response. 
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2.2.4 Procedures 
Retrospective and de-identifiable data were extracted from the RST and UPMC/CAT databases.  
Data within each database was collected beforehand and entered into each database respective to 
the seating clinic it was obtained.  Each database was comprised of similar variables which kept 
consistency between the data.  The data points extracted from the databases into the study for 
analysis were filtered out using the inclusion criteria.  All cases were de-identified before any 
data was extracted resulting in only coded data.  The de-identified data from both, the RST 
database and UPMC/CAT database was extracted and imported into a single excel document. 
2.2.5 Data Analysis 
Baseline demographics were used to determine if the three groups (SE-NSE, SE-SE, and NSE-
SE) were homogeneous.  For all tests, an alpha level of 0.05 was used.  The three groups were 
compared with respect to baseline demographics such as gender, primary diagnosis, and primary 
insurance.  All three variables were tested using a chi-square goodness of fit test between groups.  
If the test revealed a subject size under 5 then Fisher’s Exact test was utilized.  Analysis of 
Variance (ANOVA) was performed for age.  A Wilcoxon Signed Ranks Test was performed for 
each group.  The variables assessed were FMA #5 (reach), FMA #6 (transfer), and FMA total 
score within each group.  All data were analyzed using IBM SPSS Statistics Version 23 Software 
(Statistical Package for the Social Sciences Statistics).  A power analysis was conducted using 
G*Power software (Faul, 2014) to examine sample size for each FMA variable within each 
group.  The type of power analysis used was a priori and the statistical test used was a Wilcoxon 
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signed-rank test (matched pairs).  In addition, the effect size was calculated for the three groups 
and were interpreted using Cohen’s d. 
2.3 RESULTS 
Overall, 123 cases were included in this analysis.  Gender was not equally distributed between 
the three groups (Fisher’s Exact Test, p = .04) (See Table 1).  Primary diagnosis was not equally 
distributed between the three groups (Fisher’s Exact Test, p = .05) (See Table 1). Primary 
insurance was equally distributed between the three groups (Fisher’s Exact Test, p = .73) (See 
Table 1).  The effect of age was not significant (F (2,121) = 1.446, p = .24).  The data consisted 
of 89 males and 34 females (See Table 1).  The average age of the population was 49.9 with 
minimum age of 18 and a maximum age of 88.  Diagnostic information was missing on 50 of the 
cases. Of the diagnoses reported, the most prevalent primary diagnoses were multiple sclerosis 
(n=17), cerebral palsy (n=12), and muscular dystrophy (n=8) (See Table 1).  Primary insurance 
information was missing on 42 of the cases. Of the reported primary insurance variable, 
Medicare, Medicaid Advantage, or Private Insurance HMO were most prevalent (See Table 1). 
The three seat elevator groups were not evenly distributed as SE-SE and NSE-SE made up 89% 
of the data (Table 2). 
The following results relate to the SE-NSE group (See Table 3) (See Figure 1).  Time 2 
FMA #5 was significantly lower than time 1 FMA #5 (Z=-2.23, p = .03) (See Table 6).  Time 2 
FMA #6 was not significantly lower than time 1 FMA #6 (Z=-0.71, p = .48) (See Table 6).   A 
Wilcoxon Signed-Ranks Test indicated that time 2 FMA total was not statistically significantly 
lower than time 1 FMA total (Z=-0.56, p = .57) (See Table 6).   
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The following results relate to the SE-SE group (See Table 4) (See Figure 2).  Time 2 
FMA #5 was significantly higher than time 1 FMA #5 (Z=-3.42, p < .01) (See Table 6).   Time 2 
FMA #6 was significantly higher than time 1 FMA #6 (Z=-3.17, p < .01) (See Table 6).   Time 2 
FMA total was significantly higher than time 1 FMA total (Z=-3.96, p < .01) (See Table 6).    
The following results relate to the NSE-SE group (See Table 5) (See Figure 3).  Time 2 
FMA #5 was significantly higher than time 1 FMA #5 (Z=-5.37, p < .01) (See Table 6).   Time 2 
FMA #6 was significantly higher than time 1 FMA #6 (Z=-4.46, p < .01) (See Table 6).   Time 2 
FMA total was significantly higher than time 1 FMA total (Z=-5.63, p < .01) (See Table 6).   
To achieve 95% power, the effect size (R2 = 0.01 (d = 0.2)) revealed a sample size of 
N=258 for the SE-NSE group (See Table 7).  The other two groups had an adequate sample size 
(See Table 7).  Effect size was calculated in which a medium to large effect was present for the 
SE-SE and NSE-SE groups. 
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Table 1: Demographics 
  
Age (N=122) 
 Range in Years 18 - 88 
 Mean ± SD in Years 49.9 ± 15.9 
Missing 1 
  
Gender (N=123) 
 Male  N = 89 72% 
 Female N = 34 28% 
  
Primary Diagnosis (N=73) 
 Multiple Sclerosis N = 17 14% 
 Cerebral Palsy N = 12 10% 
 Muscular Dystrophy N = 8 7% 
 SCI (Paraplegia) N = 6 5% 
 SCI (Tetraplegia/Quadriplegia) N = 5 4% 
 Stroke/CVA N = 4 3% 
 Spina Bifida N = 4 3% 
 Osteoarthritis N = 3 2% 
 Rheumatoid Arthritis N = 3 2% 
 Other Neuromuscular or Congenital Disease (Not Listed Above) N = 3 2% 
 Amputation N = 2 2% 
 Amyotrophic Lateral Sclerosis/Primary Lateral Sclerosis N = 1 1% 
 Traumatic Brain Injury (TBI) N = 1 1% 
 Parkinson Disease N = 1 1% 
 Spinal Stenosis N = 1 1% 
 Osteogenesis Imperfecta N = 1 1% 
 Cerebellar Degeneration N = 1 1% 
 Missing N = 50 41% 
  
Primary Insurance (N=81) 
 Medicare N = 20 16% 
 Medicare Managed Care N = 16 13% 
 Private Insurance - HMO N = 16 13% 
 Private Insurance - Fee for Service N = 14 11% 
 Medicaid Managed Care N = 9 7% 
 Medicaid N = 6 5% 
Missing N = 42 34% 
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Table 2: Group Distribution 
Group (N=123) 
 SE-NSE N = 14 11% 
 SE-SE N = 42 35% 
 NSE-SE N = 67 54% 
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Figure 1: FMA Item #5 Score within Groups (Median) 
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Figure 2: FMA Item #6 Score within Groups (Median) 
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Figure 3: FMA Total Score within Groups (Median) 
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Table 3: Descriptive Statistics within Group 1 
SE – NSE (N = 14) 
Age 
 
  
 Mean ± SD in years 49.9 ± 16.2 
Gender 
 
  
 Male 7 50% 
 Female 7 50% 
Diagnosis 
 
  
 Multiple Sclerosis 3 21% 
 SCI (Paraplegia) 2 15% 
 Cerebral Palsy 1 7% 
 SCI (Tetraplegia/Quadriplegia) 1 7% 
 Stroke/CVA 1 7% 
 Osteoarthritis 1 7% 
 Amputation 1 7% 
 Muscular Dystrophy 1 7% 
 Spina Bifida 1 7% 
 Parkinson Disease 1 7% 
 Missing 1 7% 
Insurance 
 
  
 Medicare Managed Care 7 50% 
 Medicare 4 29% 
 Private Insurance - Fee for Service 2 14% 
 Private Insurance - HMO 1 7% 
 Missing 0 0% 
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Table 4: Descriptive Statistics within Group 2 
SE – SE (N = 42)  
Age 
 
  
 Mean ± SD in years 53.2 ± 14.4 
Gender 
 
  
 Male 28 67% 
 Female 14 33% 
Diagnosis 
 
  
 Multiple Sclerosis 7 17% 
 Cerebral Palsy 5 12% 
 Muscular Dystrophy 3 7% 
 Stroke/CVA 3 7% 
 SCI (Paraplegia) 2 5% 
 Other Neuromuscular or Congenital Disease (Not Listed Above) 2 5% 
 Traumatic Brain Injury (TBI) 1 2% 
 Osteoarthritis 1 2% 
 SCI (Tetraplegia/Quadriplegia) 1 2% 
 Cerebellar Degeneration 1 2% 
 Missing 16 38% 
Insurance 
 
  
 Private Insurance - HMO 10 24% 
 Private Insurance - Fee for Service 8 19% 
 Medicare 6 14% 
 Medicare Managed Care 4 10% 
 Medicaid 4 10% 
 Medicaid Managed Care 2 5% 
 Missing 8 19% 
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Table 5: Descriptive Statistics within Group 3 
NSE-SE (N=67) 
Age 
 
  
 Mean ± SD in years  47.9 ± 16.5 
Gender 
 
  
 Male 54 81% 
 Female 13 19% 
Diagnosis 
 
  
 Multiple Sclerosis 7 10% 
 Cerebral Palsy 6 9% 
 Muscular Dystrophy 4 6% 
 SCI (Tetraplegia/Quadriplegia) 3 5% 
 Rheumatoid Arthritis 3 5% 
 Spina Bifida 3 5% 
 SCI (Paraplegia) 2 3% 
 Amyotrophic Lateral Sclerosis/Primary Lateral Sclerosis 1 2% 
 Osteoarthritis 1 2% 
 Spinal Stenosis 1 2% 
 Osteogenesis Imperfecta 1 2% 
 Other Neuromuscular or Congenital Disease (Not Listed Above) 1 2% 
 Missing 33 49% 
Insurance 
 
  
 Medicare 10 15% 
 Medicaid Managed Care 7 10% 
 Medicare Managed Care 5 8% 
 Private Insurance - HMO 5 8% 
 Private Insurance - Fee for Service 4 6% 
 Medicaid 2 3% 
 Missing 34 51% 
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Table 6: FMA Significance Levels within Groups 
SE-NSE 
 
Time 1 Score 
Median (IQR) 
Time 2 Score 
Median (IQR)  
 FMA #5 (reach) 5.00 (1.00 – 5.25) 2.50 (1.00 – 5.00) p = 0.03 
 FMA #6 (transfer) 5.00 (2.00 – 5.00) 5.00 (2.75 – 6.00) p = 0.48 
 FMA Total 46.50 (33.25 – 52.00) 44.00 (37.00 – 50.50) p = 0.57 
SE-SE 
 
Time 1 Score 
Median (IQR) 
Time 2 Score 
Median (IQR) 
 
 FMA #5 (reach) 5.00 (2.75 – 6.00) 6.00 (5.00 – 6.00) p = 0.01 
 FMA #6 (transfer) 5.50 (4.00 – 6.00) 6.00 (5.00 – 6.00) p = 0.01 
 FMA Total 49.50 (37.00 – 55.25) 54.00 (50.75 – 59.00) p < 0.01 
NSE-SE 
 
Time 1 Score 
Median (IQR) 
Time 2 Score 
Median (IQR) 
 
 FMA #5 (reach) 4.00 (2.00 – 5.00) 6.00 (5.00 – 6.00) p < 0.01 
 FMA #6 (transfer) 5.00 (3.25 – 6.00) 6.00 (5.00 – 6.00) p < 0.01 
 FMA Total 40.00 (28.00 – 50.00) 54.00 (48.00 – 58.00) p < 0.01 
*IQR = Inter Quartile Range 
 
 
Table 7: Power Analysis (95% power (α = .05)) 
  Effect Size (d) Critical t df Sample Size (N) 
SE-NSE 
   
  
 FMA #5 (reach) 0.51 1.68 42.93 46 
 FMA #6 (transfer) 0.20 1.65 271.16 258 
 FMA Total 0.20 1.65 271.16 258 
SE-SE 
   
  
 FMA #5 (reach) 0.72 1.72 21.92 24 
 FMA #6 (transfer) 0.55 1.69 36.24 39 
 FMA Total 0.77 1.73 19.05 21 
NSE-SE 
   
  
 FMA #5 (reach) 1.09 1.80 10.46 12 
 FMA #6 (transfer) 0.72 1.72 21.92 24 
 FMA Total 1.11 1.82 9.50 11 
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2.4 DISCUSSION 
 
2.4.1 Null Hypothesis 1 (SE – NSE) 
The analysis failed to reject the first null hypothesis.  FMA item #5 showed a significant 
difference (p= .03) while FMA item #6 and FMA total were not significantly different (Table 4).  
The data shows that individuals did not present a significantly different satisfaction score for 
transferring and total FMA when a seat elevator was lost at time two.  This may likely be due to 
the small sample size of only 14 cases given the power analysis indicates a sample of 258 would 
be necessary for 95%  power (α = .05).  
2.4.2 Null Hypothesis 2 (SE – SE) 
The analysis rejected the null hypothesis as all three items from the FMA were significant (Table 
4).  All three variables showed a significant difference from time one to time two.  The data 
suggests that a new device intervention had significantly higher FMA scores when a seat elevator 
was maintained.  They were expected to stay the same.  The cause to this phenomenon could be 
due to the device at time 1 wearing out overtime or as a result of a new device and not the seat 
elevator.   
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2.4.3 Null Hypothesis 3 (NSE – SE) 
The analysis rejected the null hypothesis as all three items from the FMA were significant (Table 
4).  All three variables showed a significant difference from time one to time two.  The data 
suggests that a seating intervention when a seat elevator was obtained at time two had 
significantly higher FMA scores as they did in the SE – SE group.  The provision of a seat 
elevator as well as getting a new wheelchair may have contributed to the increase in FMA 
scores.  
2.4.4 Study Limitations 
Limitations were prevalent in this study.  One limitation of self-report questionnaires is the 
possibility of individuals responding to the questions may want to please the tool administrator 
or concerns that scores will dictate the approval or denial of a payer.  This phenomenon 
regarding self-report questionnaires could have influenced the individuals who responded to the 
FMA items.  This phenomenon is known as social desirability, whereby it has been shown that 
responses may compromise the validity of self-report measures (Malham and Saucier, 2016).  
The solution to social desirability is comparing each task of the FMA to a comparable observable 
functional task.  This would allow for the examination of associations between the user 
satisfactions with the task and the ability to perform the actual task (Schein et al., 2011).  Other 
limitations include the low number of the SE-NSE group, the missing information within the 
variables, and the amount of time between FMA time 1 scores and FMA time 2 scores.  Time 
one FMA scores were recorded between 8 April, 2008 and 18 August, 2015.  Time two FMA 
scores were recorded between 29 November, 2010 and 22 February, 2016.  In addition, the 
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follow-up FMA could have taken place over the phone, face-to-face, or through a letter in the 
mail.  The SE-NSE group had a low number of individuals included (n=14) which did not satisfy 
a reasonable sample size to show a small effect.  A power analysis was ran to achieve 95% 
power with an effect size of .02 for the SE-NSE group.  The number of individuals within this 
group was significantly lower than the power analysis recommended number of 258.  Gender 
was significantly different between the three groups (p = .04).  The RST database was only male 
which contributed to the heterogeneity of gender which needs to be further investigated.  The 
primary diagnosis variable was missing 50 cases could have influenced the relationship between 
the three groups.  The rehabilitation professionals collecting the data may have not input the data 
into the respective database which contributed to the missing data.  In addition, primary 
diagnosis was significantly different between groups (p = .05). In addition, primary insurance 
was missing 42 cases which could have been due to the same reason as primary diagnosis 
missing data.   
New technology at time two could also influence the FMA score.  The new technology 
could consist of tilt-in-space, recline, elevating leg rests, a more complex wheelchair, and/or 
alternative driving methods which all could have influenced FMA scores. 
2.4.5 Future Work 
Future work entails continuously and consistently gathering data to increase the number of 
consumers within each group.  A larger sample within the overall database would allow for more 
discrete analysis especially for discrete groups such as SE – NSE.  In addition, more organized 
data is an essential task for any future work.  A significant amount of time was spent organizing 
the data which can create burdens to busy professionals.  A better organized database would 
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allow for aggregation of data across multiple sites.  A more descript uniform dataset would also 
ensure continuity and reduce missing data.  A more organized database would pool all 
information in one place and the same variables would be collected for each subject (Kang, 
2013).  This would reduce missing data.  In addition, obtaining objective data for each individual 
within this database would be useful.  Two additional groups, in addition to the three groups 
included in this study, would aid in determining what factors contribute to SE satisfaction.  The 
two additional groups would be 1.) No seat elevator – no seat elevator (NSE-NSE_1) as a result 
of an insurance denial and 2.) No seat elevator – no seat elevator (NSE-NSE_2) as a without 
submitting for a seat elevator to insurance.  These two situations would give insight to why seat 
elevators on power wheelchairs get denied and the frequency of denial.  Other future work would 
focus on clinical changes based on the data.  The data shows that user satisfaction for reaching 
ability goes up significantly when the end-user receives a seat elevator on their new device when 
they did not have one on their old device.  This indicates that end-users may benefit from 
clinicians including seat elevators within the letter of medical necessity (LMN) when the original 
reach score on the FMA is low.  Additionally, other items on the FMA can be analyzed to see if 
seat elevators effect item #1, #2, #3, #4, #7, #8, #9, and #10.  In addition, the FMA is available to 
be taken periodically throughout the duration of the new mobility device.  This would allow the 
analysis of user satisfaction throughout the entire use of a device instead of at the end or at the 
beginning.  Lastly, FMA scores can be studied within each time point such as evaluating all of 
the groups’ time 1 scores with each other. 
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3.0  SUMMARY 
In summary, this study focused primarily on consumer satisfaction with seat elevators equipped 
or not equipped on power wheelchairs.  Gender and primary diagnosis were not accounted for as 
confounders within the analysis of primary FMA outcome variables.  However, within groups, 
the analysis revealed that when seat elevators lost during intervention, FMA #5 (reach) scores 
were significantly lower but not for FMA #6 (transfers) or total FMA scores.  In addition, within 
group scores for individuals maintaining a seat elevator and obtaining a seat elevator during 
intervention had significantly higher scores at time 2.  The significant difference in FMA scores 
for individuals maintaining a seat could account for age and reliability of an old device to a new 
mobility device at time two.  A significant difference in FMA scores could be accounted for 
within the group which obtained a seat elevator because of the seat elevator or the mobility 
device being new.  To adjust for the new device, between group differences must be accounted 
for.  Overall, the data indicated that a seat elevator equipped on a power wheelchair has a 
positive impact on user satisfaction.  
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